shortagewatch

Home / Cancer and immune system / Goserelin

ATC L02AE03 · Gonadotropin Releasing Hormone Analogues · updated 2 Nov 2026

Goserelin shortage

As of 2 Nov 2026, Goserelin has a reported shortage in 1 of the 16 countries we track (Czechia), covering 1 product from 1 company.

Is there a Goserelin shortage?

Yes. As of 2 Nov 2026, Goserelin is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 18 Dec 2026 (Czechia). New since 3 Oct 2026: Czechia.

Countries1/16
Products1packs or presentations
Companies10 listed
Short since16 Oct 202617 days ago
Earliest return18 Dec 2026company estimate
Main reasonManufacturing problem

Timeline

Czechia
2027RESELIGO 10,8MG 10,8MG IMP ISP 1RESELIGO 10,8MG 10,8MG IMP ISP 1today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Zentiva1

Compared with similar medicines

ATC group L02AE · Gonadotropin Releasing Hormone Analogues
Leuprorelin5/16Buserelin3/16Triptorelin3/16Goserelin1/16

Affected products

CountryProductCompanySinceExpected backReason
CZRESELIGO 10,8MG 10,8MG IMP ISP 1Zentiva, k.s., Praha16 Oct 202618 Dec 2026Manufacturing problem
Výrobní důvody

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Goserelin shortage?

Yes. As of 2 Nov 2026, Goserelin is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 18 Dec 2026 (Czechia). New since 3 Oct 2026: Czechia.

When will Goserelin be back in stock?

Companies expect supply back from 18 Dec 2026 in Czechia; Czechia: 18 Dec 2026. These are company estimates reported to each authority.

Why is Goserelin in short supply?

The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.

Which companies have Goserelin shortages?

Zentiva.